Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

Medable raises $300M for remote clinical trials—but what does its future look like in the post-pandemic reality?

The news: Digital clinical trial platform Medable scored $304 million in Series D funding—bringing its valuation to $2.1 billion. It plans to use the funds to build out its remote patient monitoring (RPM) infrastructure and expand its global operations.

What sets Medable apart from its competitors? It has a comprehensive suite of remote clinical trial products (eConsent, wearables, RPM, telehealth, medication adherence). And building it out further (with its new funding) will secure its spot as a market leader in decentralized clinical trials.

Trendspotting: The pandemic triggered a rapid rise in remote clinical trials—and they’re here to stay, as they make clinical trials faster and improve the experience for patients and researchers.

  • Virtual clinical trial solutions bagged a record $787 million by Q3’2020 alone—which surpassed the previous high of $403 million in 2016, per Rock Health.
  • 76% of researchers accelerated their adoption of remote clinical trials because of quarantine measures amid the pandemic, according to a November 2020 Oracle survey.
  • And more patients are likely to participate in remote trials because of the convenience factor.
  • RPM-enabled remote clinical trial platforms offer a cost-effective alternative to on-site trials and allow patients to participate from the comfort of their homes.
  • 70% of patients live more than two hours from trial sites, per Sanofi—remote clinical trials can break down transportation barriers and open up access to a larger, more diverse pool of patients.

What’s the catch? On the flipside, remote clinical trials also bring up new challenges like how variability in patients’ remote sites may influence the trial, as well as ensuring high data quality and its ability to integrate with other clinical trial platforms, and keeping up with regulatory guidances.

The most likely reality for decentralized clinical trials in a post-pandemic world? The advantages of decentralized clinical trials won’t be skirted over, but we’re most likely to see more hybrid (in-person and virtual) clinical trials as researchers aim to balance robust trial design and patient experience.